Archive:
„Gemeinsam klug entscheiden“ ist als Import aus Nordamerika eine viel und vieles versprechende Losung, die aufsetzt auf der alten Erkenntnis der Gesundheitswissenschaften wie auch zahlreicher individueller Erfahrungen, dass weniger oft mehr ist. Kluge Entscheidungen zu fördern ist ein unverzichtbares Ziel guter Medizin. Der Weg dahin könnte aber steiniger sein als viele denken.
04.06.2018
Der Innovationsfonds hat positive Impulse auf die Innovationslandschaft im Gesundheitswesen gesetzt, wodurch neue Kooperationen entstanden sind und neue Versorgungsansätze erprobt werden. Der BMC möchte die Diskussion um die Fortführung des Innovationsfonds unterstützen. Dazu engagiert sich auch unsere Arbeitsgruppe Geförderte Innovationsfondsprojekte, die intensiv an nachfolgenden Anregungen mitgewirkt hat. Weitere Anregungen und Kommentierungen sind explizit erwünscht.
04.06.2018
Vor nunmehr elf Jahren, im Januar 2007, trat die EU-Verordnung über Kinderarzneimittel in Kraft. Zielsetzung war es, Arzneimittel für die Behandlung von Kindern und Jugendlichen zur Verfügung zu stellen, deren Wirksamkeit und Unbedenklichkeit speziell für diese Altersgruppe untersucht werden. Denn Marktkräfte alleine waren nicht in der Lage ausreichende Anreize für die Forschung und das Inverkehrbringen von pädiatrischen Arzneimitteln zu generieren. Daher wurde mit der EU-Verordnung ein System implementiert, welches Verpflichtungen und Boni für den pharmazeutischen Unternehmer umfasst. INSIGHT Health analysiert im vorliegenden Beitrag dieses System am Beispiel der Verlängerung des Ergänzenden Schutzzertifikates.
04.06.2018
Reply by Prof. Dr. Norbert Schmacke, Institute for Public Health and Nursing Research at the University of Bremen (Department 1 Health Services Research) to the statement „The other person could also be right“ by Prof. Dr. Peter F. Matthiessen (Chair of the Spokesperson Committee of the Dialogue Forum Pluralism in Medicine) in MVF 03/18
04.06.2018
Benefit assessment needs new approaches. The processes are too long, patient preferences are not taken into account enough, evidence is not dynamic enough. In the fourth plenary event, around 80 experts discussed decision-making criteria, study designs and endpoints, patient preferences and innovation cycles of therapies, medications and medical devices.
04.06.2018
„The Innovation Fund has grown from a delicate seedling into a driving force in healthcare provision,“ declared Prof. Josef Hecken, impartial chairman of the G-BA and chairman of the Innovation Committee, with evident pride. He presented a „positive and solid interim assessment“ to over 600 attendees of the G-BA congress „Two Years of the Innovation Fund – Driving Force for Better Healthcare.“ However, the congress not only discussed the past and present in detail, but also the future allocation and distribution of Innovation Fund resources from 2019 onward.
04.06.2018
„This is a huge opportunity to move away from clawbacks. The physician should be responsible for evidence-based therapy, dosage, and drug selection, but not for the price,“ said Dr. Regina Feldmann, then a board member of the National Association of Statutory Health Insurance Physicians, regarding the new regional agreements. The prescription quotas and care targets contained therein are intended to ensure cost-effective drug prescribing and provide patients with high-quality care. Depending on which drug groups are assigned which targets, the regional structure can contribute to cost-effective prescribing practices, even though this certainly depends on numerous other factors. This article uses selected examples to demonstrate whether steering effects occur.
04.06.2018
“It is time to look at people, individuals, people,” says Prof. Dr. med. Dr. phil. Dipl.-Psych. Martin Härter, the President of the 17th German Congress for Health Care Research in the cover interview with “Monitor Health Care Research”. The 17th DKVF has therefore chosen the motto “People-centered research, design and care”, which will be discussed with many national and international speakers.
04.06.2018
Coordinating cooperation, promoting research and improving care - that is the motto of the Hamburg Network for Health Services Research (HAM-NET), which was founded on February 1, 2017 with the help of BMBF funding and has been active in the Hamburg metropolitan region ever since. The German healthcare system is characterized by numerous actors and is structured in a complex manner. Health care research to improve health care must therefore always be thought of in an interdisciplinary manner. Accordingly, over 30 institutions from all relevant players in the Hamburg healthcare system have already networked in the HAM-NET.
04.06.2018
Psychosocial medicine and the University Hospital Hamburg-Eppendorf, which will be celebrating its 130th birthday next year, cannot be separated: as early as 1970, psychosocial subjects were introduced into the licensing regulations for doctors for the first time, psychosomatic connections were discussed, and the purely medical concept of illness was thus called into question placed. These many years of experience gave rise to the UKE polyclinic, which is still operating successfully today - with a particular focus on the support and treatment of seriously and chronically ill people and their relatives on the one hand, and rehabilitation and health care research on the other, with the appointment back in 1993 Uwe Koch-Gromus established him as director. In 2002 the department changed its name to “Institute and Polyclinic for Medical Psychology”, which has been headed by Prof. Dr. med. med. Dr. phil. Dipl.-Psych. Martin Härter is in charge.